
Collaboration - May 4, 2015
Recipharm, Follicum Ink Pact
Recipharm has signed an agreement of cooperation with Follicum AB prior to a clinical trial for the drug candidate FOL-005th, which is being developed to stimulate or inhibit hair growth for both men and women, without side effects. Recipharm has been commissioned to formulate and produce the product that will be used in the clinical […]